UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash Flows From Operating Activities:
Net earnings	$ 21,429	$ 16,441
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:
Depreciation and amortization	7,631	7,359
Provision for credit losses, inventory obsolescence and sales returns	245	211
Share-based compensation expense	2,247	1,954
Excess tax benefit from share-based compensation	(824)	(1,536)
Payments from lessees directly to lenders-operating leases	(4,445)	(4,062)
Gain on disposal of property, equipment and operating lease equipment	(2,120)	(1,001)
Gain on sale of financing receivables	(3,179)	(4,025)
Gain on settlement	(1,434)	0
Other	50	42
Changes in:
Accounts receivable - trade	13,236	12,897
Accounts receivable - other	(854)	(4,087)
Inventories	(7,006)	(5,043)
Financing receivables	(14,187)	(8,193)
Deferred costs, other intangible assets and other assets	1,333	1,513
Accounts payable-equipment	(162)	1,700
Accounts payable-trade	(29,315)	(222)
Salaries and commissions payable, deferred revenue and other liabilities	6,360	(8,387)
Net cash (used in) provided by operating activities	(10,995)	5,561
Cash Flows From Investing Activities:
Maturities of short-term investments	0	982
Proceeds from Sale of Held-to-maturity Securities	2,544	0
Proceeds from sale of property, equipment and operating lease equipment	5,751	1,929
Purchases of property, equipment and operating lease equipment	(1,919)	(6,759)
Purchases of assets to be leased or financed	(10,000)	(7,032)
Issuance of financing receivables	(51,163)	(45,847)
Repayments of financing receivables	28,082	16,031
Proceeds from sale of financing receivables	12,341	15,456
Premiums paid on life insurance	0	(93)
Cash used in acquisitions, net of cash acquired	(7,818)	0
Net cash used in investing activities	(22,182)	(25,333)
Cash Flows From Financing Activities:
Borrowings of non-recourse and recourse notes payable	30,104	12,779
Repayments of non-recourse and recourse notes payable	(802)	(1,135)
Repurchase of common stock	(34,782)	(5,901)
Dividends paid	(90)	(105)
Proceeds from issuance of capital stock through option exercise	0	559
Payments of contingent consideration	0	(1,027)
Excess tax benefit from share based compensation	824	1,536
Net borrowings (repayments) on floor plan facility	20,694	14,042
Net cash provided by financing activities	15,948	20,748
Effect of exchange rate changes on cash	(9)	0
Net Increase in Cash and Cash Equivalents	(17,238)	976
Cash and Cash Equivalents, Beginning of Period	80,179	52,720
Cash and Cash Equivalents, End of Period	62,941	53,696
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	128	15
Cash paid for income taxes	12,770	10,334
Schedule of Non-Cash Investing and Financing Activities:
Purchase of property and equipment included in accounts payable	232	71
Purchase of operating lease equipment included in accounts payable	103	241
Purchase of assets to be leased or financed included in accounts payable	18,578	10,664
Proceeds from sales of operating lease equipment included in accounts receivable	910	12
Repayments of non-recourse and recourse notes payable	19,171	9,715
Vesting of share-based compensation	6,407	7,769
Origination and concurrent sale of financing receivables	47,213	80,769
Contingent consideration	$ 1,960	$ 0